Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,64118,660 of 20,252 grants

Completed TRAINING, INDIVIDUAL
Metabolic Contributions of Individual Cellular Compartments to the Diversity of the Tumor Microenvironment in Renal Cell Carcinoma
NATIONAL CANCER INSTITUTE Vanderbilt University United States 2021 – 2023

PROJECT SUMMARY Deregulating cellular energetics and avoiding immune destruction are considered hallmarks of cancer. Stimulating anti-tumor immunity is now a chief goal of cancer t...

$264.1K
USD
Completed NON-SBIR/STTR RPGS
Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive disease
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

PROJECT SUMMARY The lifetime risk for acquiring colorectal cancer (CRC) is 7%, with an astounding rate of disease recurrence in 32% of newly diagnosed patients after their “success...

$6.07M
USD
Completed NON-SBIR/STTR RPGS
Epigenetic Control and Genome Organization
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

OVERALL PROGRAM SUMMARY Gary Stein and Janet Stein, Program Directors Our Program Project is a thematically, experimentally and operationally integrated multidisciplinary team appr...

$17.35M
USD
Completed NON-SBIR/STTR RPGS
Project 1: Mitotic Gene Bookmarking as an Epigenetic Mechanism to Maintain the Mammary Epithelial Phenotype
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

PROJECT 1 | SUMMARY Mechanisms underlying the epithelial to mesenchymal transition (EMT)—a normal developmental process and an early event at the onset of epithelium-derived cancer...

Completed OTHER RESEARCH-RELATED
Investigating Transcriptional Elongation and Nuclear RNA Surveillance in Melanoma
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

Project Summary Metastatic melanoma, a cancer derived from pigment-producing melanocytes, is the deadliest type of skin cancer. Metastatic melanoma that is refractory or resistant...

$1.96M
USD
Completed NON-SBIR/STTR RPGS
Project 2: Bromodomains as Epigenetic Modulators of Endocrine Responsiveness in ER+ Breast Cancer
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

PROJECT 2: SUMMARY Breast cancer (BCa) ranks among the leading causes of cancer death in women worldwide. Estrogen Receptor alpha positive tumors (ER+) are the most common subtype...

Completed NON-SBIR/STTR RPGS
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast Cancer
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

SUMMARY Long non-coding RNAs (lncRNAs) are epigenetic regulators of the chromatin organization supporting cancer cell activities. There is a gap in the literature identifying the c...

Completed NON-SBIR/STTR RPGS
Administration and Coordination Core
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

SUMMARY/ABSTRACT Administration and Coordination Core Gary Stein, Core Leader; Janet Stein, Co-Leader The Administration and Coordination Core will provide leadership, and administ...

Completed NON-SBIR/STTR RPGS
Experimental Integration, Design and Analysis Core
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

Summary: Experimental Integration, Design and Analysis Core The Experimental Integration, Design, and Analysis (EIDA) Core is an essential component of the program project that is...

Completed NON-SBIR/STTR RPGS
Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2026

Project Abstract Live cell reporters of genetic changes in stiff vs soft surroundings – causes & consequences Solid tumors are often palpably stiff and more constrained in 3D g...

$7.79M
USD
Completed TRAINING, INDIVIDUAL
Lipid metabolism as a therapeutic vulnerability in BET inhibitor-resistant medulloblastoma
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2024

Project Summary/Abstract MYC-driven medulloblastomas are a particularly devastating group of pediatric brain tumors that exhibit resistance and continued progression despite standa...

$717.9K
USD
Completed TRAINING, INDIVIDUAL
Mechanisms of cysteinyl leukotriene receptor 2 (CysLT2R)-mediated signaling and migration in melanocytes and uveal melanoma
NATIONAL CANCER INSTITUTE Brown University United States 2021 – 2023

PROJECT SUMMARY (ABSTRACT) Melanocytes comprise a heterogeneous group of neural crest-derived cells that are present in the skin, eyes, ear, heart, and brain. While the function of...

$226.7K
USD
Completed NON-SBIR/STTR RPGS
Predicting sensitivity and resistance in RET-driven cancers
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Selpercatinib (LOXO-292) is a highly active selective RET inhibitor explored on an ongoing registrational program (LIBRETTO-001 phase 1/2 trial) in RET-dependent cancers (US FDA ap...

$3.97M
USD
Completed NON-SBIR/STTR RPGS
HER2-mediated delivery of cytotoxic agents in solid tumors
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2025

PROJECT SUMMARY ERBB2/HER2 is a receptor tyrosine kinase (RTK) that is amplified/overexpressed in 15-20% of breast and gastroesophageal cancers, for which anti-HER2 therapy is now...

$5.76M
USD
Completed NON-SBIR/STTR RPGS
Understanding the role of TP53 mutation in genetic susceptibility to ovarian cancer
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2026

Project Summary Understanding the role of TP53 mutation in genetic susceptibility to ovarian cancer Women with germline mutations in BRCA1 and BRCA2 (BRCA carriers) are at high ris...

$5.13M
USD
Completed NON-SBIR/STTR RPGS
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

Summary. In triple-negative breast cancer and high-grade serous ovarian cancer, the emergence of resistance to therapy is virtually inevitable and contributes to dismal long-term p...

$5.17M
USD
Completed NON-SBIR/STTR RPGS
Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation
NATIONAL CANCER INSTITUTE Jackson Laboratory United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Metastatic disease remains the major cause of cancer-related death. Among the vital organs to which solid tumors metastasize, the lung is one of the most c...

$4.75M
USD
Completed NON-SBIR/STTR RPGS
TRIM37 is a genetic determinant of racial disparity in metastatic TNBC patients
NATIONAL CANCER INSTITUTE University of California At Davis United States 2021 – 2026

African American (AA) women presents with aggressive metastatic subtype of triple negative breast cancer (TNBC) compared to other ethnicities and experience greater mortality rates...

$4.68M
USD
Completed NON-SBIR/STTR RPGS
Deconstructing and targeting aneuploidy in human cancer - Resubmission - 1
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2026

Summary Aneuploidy—the presence of chromosome gains and losses—is very rare in normal tissues but occurs in more than 80% of human tumors, especially in solid tumors. A high level...

$4.82M
USD
Completed NON-SBIR/STTR RPGS
Defining the role of BARD1 in nucleosomal ubiquitylation
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2026

PROJECT SUMMARY BARD1 (BRCA1-Associated RING Domain protein-1) is an essential partner of the breast and ovarian cancer tumor-suppressor protein, BRCA1, and is included in a panel...

$5.27M
USD